Your Health, We Care
Ritlecitinib is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents12 years and older.
Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.
from FDA，2023.06
Suitable for treating severe alopecia areata in adults and adolescents aged 12 a···【more】
Release date：2026-01-06Recommended：0
